BillionToOne has filed a notice of an exempt offering of securities to raise $83,500,000.00 in New Equity and Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, BillionToOne is raising $83,500,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Oguzhan Atay played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About BillionToOne
BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible. Our proprietary molecular counting platform can accurately count DNA molecules at the single-count level to help improve disease detection.
To learn more about BillionToOne, visit http://www.billiontoone.com/
Contact:
Oguzhan Atay, Chief Executive Officer
650-460-2551
SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved